Literature DB >> 11149656

Circulating soluble adhesion molecules in patients with systemic sclerosis: correlation between circulating soluble vascular cell adhesion molecule-1 (sVCAM-1) and impaired left ventricular diastolic function.

A A Shahin1, S Anwar, A H Elawar, A E Sharaf, M A Hamid, A A Eleinin, M Eltablawy.   

Abstract

The objective of this paper is to investigate the relation between circulating soluble adhesion molecules and cardiac involvement, as assessed by echocardiography in patients with systemic sclerosis (SSc). Nineteen patients with SSc were submitted for assessment of serum levels of circulating soluble intercellular adhesion molecules (sICAM-1), and soluble vascular cell adhesion molecules-1 (sVCAM-1), and echocardiography. Abnormal left ventricular filling patterns (down E/A ratio) were detected in ten patients (52.6%) with significant negative correlation with sVCAM-1 (r = -0.484, P < 0.05). It was also significantly correlated with age (r = -0.791, P < 0.01), age of onset (r = -0.468, P < 0.05), degree of dyspnea (r = -0.687, P < 0.01), and erythrocyte sedimentation rate (ESR) (r = -0.489, P < 0.05). Our findings suggest an important role for sVCAM-1 as a marker of disease severity and impaired left ventricular filling pattern in SSc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149656     DOI: 10.1007/s002960000072

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

Review 1.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

2.  VCAM-1 is a TGF-β1 inducible gene upregulated in idiopathic pulmonary fibrosis.

Authors:  Marianna Agassandian; John R Tedrow; John Sembrat; Daniel J Kass; Yingze Zhang; Elena A Goncharova; Naftali Kaminski; Rama K Mallampalli; Louis J Vuga
Journal:  Cell Signal       Date:  2015-09-18       Impact factor: 4.315

3.  Novel insight into the genetic basis of high-altitude pulmonary hypertension in Kyrgyz highlanders.

Authors:  Arya Iranmehr; Tsering Stobdan; Dan Zhou; Orit Poulsen; Kingman P Strohl; Almaz Aldashev; Amalio Telenti; Emily H M Wong; Ewen F Kirkness; J Craig Venter; Vineet Bafna; Gabriel G Haddad
Journal:  Eur J Hum Genet       Date:  2018-09-25       Impact factor: 4.246

4.  Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.

Authors:  Yannick Allanore; Didier Borderie; Hervé Lemaréchal; Ohvanesse Garabed Ekindjian; André Kahan
Journal:  Arthritis Res Ther       Date:  2004-05-12       Impact factor: 5.156

5.  Bosentan regulates the expression of adhesion molecules on circulating T cells and serum soluble adhesion molecules in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  F Iannone; M T Riccardi; S Guiducci; R Bizzoca; M Cinelli; M Matucci-Cerinic; G Lapadula
Journal:  Ann Rheum Dis       Date:  2007-11-20       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.